Building Programs to Eradicate Toxoplasmosis Part II: Education.
Education
Primary prevention
Toxoplasma
Toxoplasmosis
Journal
Current pediatrics reports
ISSN: 2167-4841
Titre abrégé: Curr Pediatr Rep
Pays: Germany
ID NLM: 101600850
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
entrez:
27
3
2023
pubmed:
28
3
2023
medline:
28
3
2023
Statut:
ppublish
Résumé
Review work to create and evaluate educational materials that could serve as a primary prevention strategy to help both providers and patients in Panama, Colombia, and the USA reduce disease burden of Educational programs had not been evaluated for efficacy in Panama, USA, or Colombia. Educational programs for high school students, pregnant women, medical students and professionals, scientists, and lay personnel were created. In most settings, short-term effects were evaluated. In Panama, Colombia, and USA, all materials showed short-term utility in transmitting information to learners. These educational materials can serve as a component of larger public health programs to lower disease burden from congenital toxoplasmosis. Future priorities include conducting robust longitudinal studies of whether education correlates with reduced adverse disease outcomes, modifying educational materials as new information regarding region-specific risk factors is discovered, and ensuring materials are widely accessible.
Identifiants
pubmed: 36969368
doi: 10.1007/s40124-022-00267-y
pmc: PMC10035399
mid: NIHMS1832235
doi:
Types de publication
Journal Article
Langues
eng
Pagination
93-108Subventions
Organisme : NIAID NIH HHS
ID : R01 AI027530
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI082180
Pays : United States
Organisme : NIDDK NIH HHS
ID : T35 DK062719
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI077887
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI043228
Pays : United States
Déclaration de conflit d'intérêts
Conflict of Interest Denis Limone Pharm D,is Chairman , shareholder and CEO and Raphael Piarroux Pharm D, PhD, is RandD Director and employee at LDBio Diagnostics. A patent application was submitted in the United States for the development of the whole blood point of care test with the scientists at the University of Chicago to insure its continued high quality performance and reproducibility. The authors declare no other competing interests..
Références
Rev Inst Med Trop Sao Paulo. 2014 Sep-Oct;56(5):433-8
pubmed: 25229225
Int J Adolesc Med Health. 2020 Feb 28;34(3):
pubmed: 32109206
Arch Gynecol Obstet. 2015 Mar;291(3):545-55
pubmed: 25205181
Emerg Microbes Infect. 2018 Sep 27;7(1):165
pubmed: 30262847
Glob J Health Sci. 2013 Jun 21;5(5):131-43
pubmed: 23985115
J Perinat Med. 2004;32(3):211-4
pubmed: 15188792
Infect Dis Obstet Gynecol. 2003;11(3):139-45
pubmed: 15022874
Gac Med Mex. 2011 Jul-Aug;147(4):311-24
pubmed: 21894229
Med Pr. 2010;61(3):271-6
pubmed: 20677426
Cochrane Database Syst Rev. 2015 Oct 23;(10):CD006171
pubmed: 26493047
PLoS One. 2019 Sep 9;14(9):e0222094
pubmed: 31498820
Zoonoses Public Health. 2010 Feb;57(1):27-33
pubmed: 19744302
Bull World Health Organ. 2013 Jul 1;91(7):501-8
pubmed: 23825877
Epidemiol Infect. 2020 Oct 07;148:e256
pubmed: 33023706
Int J Parasitol. 2009 Oct;39(12):1385-94
pubmed: 19433092
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2016 Dec 5;28(6):664-668
pubmed: 29469258
Srp Arh Celok Lek. 2015 Jul-Aug;143(7-8):438-45
pubmed: 26506754
Epidemiol Serv Saude. 2016 Jul-Sep;25(3):655-661
pubmed: 27869937
Mem Inst Oswaldo Cruz. 2009 Mar;104(2):320-44
pubmed: 19430661
Eur J Obstet Gynecol Reprod Biol. 2008 Feb;136(2):137-45
pubmed: 17977641